Clincosm LogoSign in Get a demo

squamous cell carcinoma of head and neck

Showing 51 - 75 of 105
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in Grand Rapids, New York, Houston (NGM438, Pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Grand Rapids, Michigan
  • +2 more
Jul 18, 2022

NSCLC, Carcinoma, Renal Cell, Esophageal Squamous Cell Carcinoma Trial (QEQ278)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +3 more
  • QEQ278
  • (no location specified)
Jul 14, 2022

Melanoma, NSCLC, Squamous Cell Carcinoma of Head and Neck Trial in United States (GEN-011, IL-2, Fludarabine)

Terminated
  • Melanoma
  • +8 more
  • GEN-011
  • +3 more
  • Gilbert, Arizona
  • +7 more
Jul 13, 2022

Squamous Cell Carcinoma of Head and Neck, Neoadjuvant Therapy, Resection Margin Trial in Wuhan (Reducing Excision Margins)

Active, not recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +2 more
  • Reducing Excision Margins
  • Wuhan, Hubei, China
    Zhanjie Zhang
Jul 11, 2022

Cervical Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, Microsatellite Stable Colorectal Cancer Trial in Worldwide

Recruiting
  • Cervical Cancer
  • +4 more
  • La Jolla, California
  • +19 more
Jun 28, 2022

Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)

Recruiting
  • Ovarian Cancer
  • +10 more
  • West Hollywood, California
  • +27 more
Jun 27, 2022

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in United States (NGM831, NGM831 plus pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Gilbert, Arizona
  • +4 more
Jun 21, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Spain, United States (REGN6569, Cemiplimab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Los Angeles, California
  • +9 more
Jun 20, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Aurora, Colorado Springs, Highlands Ranch (Atezolizumab, Stereotactic Body

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Aurora, Colorado
  • +3 more
Jun 15, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Charleston (NDURE)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • NDURE
  • Charleston, South Carolina
    Medical University of South Carolina
May 25, 2022

Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck Trial in United States (Drug: SL-172154)

Terminated
  • Cutaneous Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Head and Neck
  • Drug: SL-172154
  • Los Angeles, California
  • +5 more
May 18, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Worldwide (Atezolizumab, Tiragolumab, Placebo)

Active, not recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • La Jolla, California
  • +57 more
May 18, 2022

Solid Tumor, Adult, Squamous Cell Carcinoma of Head and Neck, Colorectal Adenocarcinoma Trial in United States (NT219, NT219 and

Recruiting
  • Solid Tumor, Adult
  • +5 more
  • Encinitas, California
  • +6 more
May 2, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Newark, Stratford (MASL, Placebo)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Newark, New Jersey
  • +3 more
Apr 26, 2022

Squamous Cell Carcinoma of Head and Neck, Colo-rectal Cancer, Non Small Cell Lung Cancer Trial in Aurora, Nashville, Houston

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +4 more
  • Aurora, Colorado
  • +2 more
Apr 18, 2022

Urothelial Carcinoma, Triple Negative Breast Cancer, NSCLC Trial (SBT6290, pembrolizumab)

Withdrawn
  • Urothelial Carcinoma
  • +4 more
  • (no location specified)
Apr 4, 2022

Squamous Cell Carcinoma of Head and Neck Trial in France (bintrafusp alfa)

Terminated
  • Squamous Cell Carcinoma of Head and Neck
  • bintrafusp alfa
  • Bordeaux, France
  • +7 more
Mar 28, 2022

NSCLC, Triple Negative Breast Tumors, Squamous Cell Carcinoma of Head and Neck Trial in United States (Pembrolizumab, TAK-676,

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • West Hollywood, California
  • +5 more
Mar 17, 2022

Squamous Cell Carcinoma of Head and Neck Trial (Lara Scan, PET/CT Scan - Pre-treatment and Post-treatment)

Withdrawn
  • Squamous Cell Carcinoma of Head and Neck
  • Lara Scan
  • PET/CT Scan - Pre-treatment and Post-treatment
  • (no location specified)
Mar 11, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Nice (Cisplatin, Nivolumab, RT)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Nice, France
    Centre Antoine Lacassagne
Mar 10, 2022

Nivolumab in Routine Oncology Practice in China

Recruiting
  • Non-Small Cell Lung Cancer
  • Squamous Cell Carcinoma of Head and Neck
    • Beijing, Beijing, China
    • +1 more
    Feb 25, 2022

    Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

    Recruiting
    • Malignancy
    • +14 more
    • Scottsdale, Arizona
    • +17 more
    Mar 7, 2022

    Advanced Cancer, Metastatic Cancer, Squamous Cell Carcinoma of Head and Neck Trial in United States (FS118)

    Recruiting
    • Advanced Cancer
    • +2 more
    • Los Angeles, California
    • +6 more
    Mar 3, 2022

    Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Cancer, Melanoma Trial in Worldwide (MGC018, retifanlimab)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • +5 more
    • MGC018
    • retifanlimab
    • Santa Monica, California
    • +19 more
    Feb 14, 2022

    Advanced Solid Tumor, NSCLC, Squamous Cell Carcinoma of Head and Neck Trial in United States (MT-6402)

    Recruiting
    • Advanced Solid Tumor
    • +2 more
    • Los Angeles, California
    • +7 more
    Feb 25, 2022